pretickt

When does Bio-Techne report earnings?

Bio-Techne Corporation · end-of-day data as of Nov 13, 2026

Bio-Techne
TECH · $11.44B
$72.80+0.1%
Nov 13, 2026 · close
$72SepOctNov9:3016:003 months +1.0%Nov 13 · close
▲ 4
  • P/E vs own-16.7%
  • MAs4 of 4
  • MACD0.01
  • Sector▲ +15.9%
Neutral
  • Earnings in81d
  • P/E66.2x
  • RSI65
  • Support-1.5%
  • Resistance+5.9%
  • Off 52w high-0.1%
  • Volume0.8x
  • Bollingerupper half
  • News0.00
  • FCF yield+2.7%
  • ConsensusHold · 13
  • Trendsideways
  • 52w range$43–$73
  • ATR+0.2%
  • Off ATH-46.5%
  • InsidersNone in 90d
▼ 2
  • PT$67.18 -7.7%
  • P/E vs sector+105.4%

Updates with the 15-min delayed price. Not a forecast or investment advice.

Bio-Techne TECH reports its next earnings on Tuesday, Feb 2, 2027, an estimated date the company has not confirmed yet. Analysts expect EPS of $0.47 on revenue of $309M. Bio-Techne beat the EPS estimate in 4 of its last 8 reports, and the stock moved ±4.9% on average the session after. The last report, on Nov 6, 2026: EPS of $0.44 against $0.44 expected and revenue of $300M against $293M; the stock rose 0.1% the next session.

The stock around its reports

⇔⇕$45.34$55.41$65.47$75.54Nov 24Apr 25Sep 25Feb 26Jul 26Dec 26EDAAAEDEDAAEDAEDEDAAAAEADDEDE

Last close $72.80 · -1.3% over 2y · E earnings · D dividend · S split · A analyst rating change

Quarterly results

Q1 FY2027: Revenue +4.6% year over year, free cash flow 22.4% of revenue, operating margin 12.2%.

RevenueFree cash flow
Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Q1 FY2027Sep 30, 2026$300M0.18$67.2M65.6%12.2%9.4%
Q4 FY2026Jun 30, 2026$321M0.36$86.94M65.8%23.1%17.0%
Q3 FY2026Mar 31, 2026$311M0.32$77.58M66.9%24.2%16.4%
Q2 FY2026Dec 31, 2025$296M0.24$76.49M64.6%18.4%12.8%
Q1 FY2026Sep 30, 2025$287M0.24$22.22M65.6%16.6%13.3%
Q4 FY2025Jun 30, 2025$317M-0.11$93.31M62.7%-7.5%-5.6%
Q3 FY2025Mar 31, 2025$316M0.14$31M67.9%12.2%7.1%
Q2 FY2025Dec 31, 2024$297M0.22$77.53M65.3%16.0%11.7%